Outlook Therapeutics Incs. (OTLK) PT Raised to $7.50 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts OTLK Hot Sheet
Price: $0.76 -14.61%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo raised the price target on Outlook Therapeutics Incs. (NASDAQ: OTLK) to $7.50 (from $7.25) while maintaining a Buy rating.
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
